Metformin attenuates progression of carotid arterial wall thickness in patients with type 2 diabetes
- 1 June 2004
- journal article
- research article
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 64 (3) , 225-228
- https://doi.org/10.1016/j.diabres.2003.11.007
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Correlation between common carotid arterial wall thickness and ischemic stroke in patients with type 2 diabetes mellitusMetabolism, 2002
- An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats.Diabetes, 1999
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Potent Inhibitory Effect of Troglitazone on Carotid Arterial Wall Thickness in Type 2 DiabetesJournal of Clinical Endocrinology & Metabolism, 1998
- MetforminNew England Journal of Medicine, 1996
- Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995
- Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid arteryDiabetologia, 1995
- Effects of Metformin on Insulin Resistance, Risk Factors for Cardiovascular Disease, and Plasminogen Activator Inhibitor in NIDDM Subjects: A study of two ethnic groupsDiabetes Care, 1993
- Prevalence of Carotid Atherosclerosis in Diabetic Patients Ultrasound high-resolution B-mode imaging on carotid arteriesDiabetes Care, 1992
- Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.Circulation, 1986